CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. But even with the TTOR’s focus on prevention, treatment, and recovery, illicit operations continue to wreak havoc. Interestingly, although opioids work well for acute pain (e.g.,

Programs 52

Programs Chronic Pain Treatment Conditions 52

Freedom Leaf

OCTOBER 15, 2018

On the basis of their review, the agency approved Epidiolex for use in treating rare forms of childhood epilepsy (Lennox-Gastaut syndrome and Dravet syndrome). Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S. will top $1.9 billion by 2022.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

The Joint Blog

JANUARY 12, 2020

Passage of the 2018 Farm Bill, which eased federal legal restrictions on hemp cultivation and transport, unleashed a stampede of companies rushing products to the market in an absence of regulations ensuring safety, quality and effectiveness. “The “The product is good, it just didn’t work for my dog,” she said.

Pets 36

Pets CBD Clinical Trials Research and Development 36

Cannabis Law Report

AUGUST 5, 2019

When it comes to food or “health” products containing cannabidiol, commonly known as CBD, the federal government is not keeping up with the marketplace, where sales of CBD products topped $500 million in 2018. Read more. . Leafwire Closes $1M Funding Round. . ” Read more. . Read more. . Medical Marijuana, Inc.

Law 40

Law Decriminalization Hemp Legislation 40

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaMD

SEPTEMBER 15, 2020

SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Patients suffering from cancer, epilepsy, chronic seizures, or muscle spasms could use low-THC cannabis products recommended by a licensed doctor. .’ Qualified patient.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

OCTOBER 5, 2020

Hawaii legalized cannabis in its’ House Bill 2729 which was passed in 2018. According to data from another American state, Colorado, cannabis edibles account for as much as 45% of all cannabis sales – which excludes those home-made edibles made from bought or grown cannabis bud (the flower we consume).

Edibles 52

Edibles Legalization Decriminalization Consumption 52

Cannabis Law Report

DECEMBER 9, 2019

Although official uses (outside of treatment for childhood epilepsy) have not been officially approved by the FDA, early results from research has resulted in consumers flocking to the compound of their own accord and at their own risk. pet owners spent over $70 billion in 2018 on non-CBD products for their pets.

Pets 59

Pets CBD Research and Development Epilepsy 59

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Silver Spring, MD: US Food and Drug Administration; June 25, 2018.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 26, 2021

MYMD-1’s primary purpose is to slow the aging process and extend healthy lifespan, and it is also showing promise as a potential treatment for post- COVID-19 complications and as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Dr. Dawn Boothe is a professor of veterinary physiology and pharmacology at Auburn University studying cannabis’s potential as a veterinary treatment. Earlier this year, Gov. Cats are more challenging.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

Cannabis Law Report

MAY 17, 2019

billion in 2018 domestic sales and, after the Agriculture Improvement Act of 2018 (“Farm Bill”) removed them from the Controlled Substance Act, 21 U.S.C. §§ 801, Et. ’s largest CBD firms achieved record Q3 2018 revenues including: $17.7 million by Charlotte’s Web (maker of products sold in 3,000 U.S.

Food 10

Food DEA Hemp CBD 10

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. 2018 ; Frankhauser 2008 ). Refractory paediatric epilepsy. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52

CannaTech

SEPTEMBER 23, 2019

In the UK, cannabis-based medicinal products (CBMP) were legalized in November 2018. This bottleneck has left patients and parents to pursue unregulated avenues to access treatment. In the case of cannabis, these interests were absent, constituting an additional reason for limited clinical trial data on cannabis.

Patients 79

Patients Policy Clinical Trials Research and Development 79

Cannabis Law Report

OCTOBER 26, 2019

The TGA does not evaluate any data relating to the trial. In 2018, an online system was introduced to enable electronic submission of SAS and authorised prescriber applications to the TGA. 2) (2018 Code) is required (see also Section IX.i The institution at which the trial will be conducted gives the final approval.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Weedistry

MARCH 8, 2019

In 2018, medical cannabis became legal in the UK after a nationwide outpouring of support for two young boys who rely on cannabis oil to treat their severe and rare forms of epilepsy, but lingering concerns around the safety and efficiency of the medicine mean that access is still heavily restricted. Results of the treatment.

Oil 40

Oil Treatment Patients THC 40

Puff Puff Post

DECEMBER 28, 2018

An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. The Current Treatments for Autism. Most education-based autism treatment is focused on teaching developing children self-care, communicative, and social skills. As it sits, only a few methods of treating autism are available.

Treatment 76

Treatment Oil CBD Therapy 76

Green Relief

MAY 13, 2018

LEE ON MAY 02, 2018. It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. But the U.S. BY MARTIN A.

THC 64

THC CBD Cannabinoids Research and Development 64

Sensi Seeds

DECEMBER 10, 2018

They evaluate data, which is now available thanks to the efforts of the cannabis policy reform movement, and try to provide answers, especially to those who need them most, namely, medical patients. Consequently, they sorted the publications into three main groups: psychiatry, cancer treatment, and neurology.

Medicine 81

Medicine Research and Development Data Policy 81

Green Relief

MAY 12, 2018

LEE ON MAY 02, 2018. It is the most commonly identified cause of epilepsy among adults. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. Preliminary data suggests that a synergistic combination of CBD and hypothermia may produce the best results. But the U.S. BY MARTIN A.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

JULY 12, 2019

Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Chronicles

JANUARY 2, 2019

drug regulators approved the first marijuana-based pharmaceutical to treat kids with a form of epilepsy, and billions of investment dollars poured into cannabis companies. It’s a non-psychoactive compound found in marijuana and hemp plants and used for treatment of certain medical problems. It’s not just the U.S.

Legalization 100

Legalization Research and Development Recreational Data 100

Cannabis Law Report

SEPTEMBER 12, 2019

In December 2018, Jeff Smith predicted that Florida’s $250M medical cannabis market could open up to new businesses in 2019 : “Florida’s $250 million medical marijuana market is poised to swing its doors open to new companies next year after two judicial rulings in recent months that could reshape the competitive landscape.

Seed-To-Sale 65

Seed-To-Sale Supply Chain Business Programs 65

The Cannigma

SEPTEMBER 15, 2022

As our body of research expands, new avenues of potential treatment emerge for conditions that were previously overlooked. People with autism often have comorbid diagnoses such as anxiety, depression, sleep disturbances, ADHD, epilepsy, allergies, autoimmune conditions, and gastrointestinal conditions.

Terpenes 91

Terpenes Strains Sleep THC 91

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. and, in some cases, contradictory. The first, Sativex, is owned by? GW Pharmaceuticals ?and

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

OCTOBER 17, 2019

Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. billion in 2018, and with a compound annual growth rate of 23.9%, is predicted to reach $66.3 billion in 2025, according to Grandview Research. plants with.3%

Law 40

Law Seed-To-Sale Hemp Recreational 40